IFF
60
-2
OKE
71
-2
WEC
45
-5
NEM
41
-7
PG
53
-2
EFX
69
-5
CHK
5
-17
PAYX
51
-3
ADI
51
-3
PRGO
46
-4
KMX
48
-2
SE
55
-3
ADSK
57
-4
STT
42
-6
BBY
63
3
ESS
60
-7
D
58
-2
MCHP
32
-6
TJX
51
-3
C
47
-4
IFF
60
-2
OKE
71
-2
WEC
45
-5
NEM
41
-7
PG
53
-2
EFX
69
-5
CHK
5
-17
PAYX
51
-3
ADI
51
-3
PRGO
46
-4
KMX
48
-2
SE
55
-3
ADSK
57
-4
STT
42
-6
BBY
63
3
ESS
60
-7
D
58
-2
MCHP
32
-6
TJX
51
-3
C
47
-4
Financhill
Back

SpringWorks Therapeutics Quote, Financials, Valuation and Earnings

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.
Sell
22

SWTX
SpringWorks Therapeutics

Last Price:
38.69
Seasonality Move:
12.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Potential crash warning signs flashing again on my charts

Here's my #1 indicator to try out now.

SpringWorks Therapeutics Price Quote

$38.69
-0.01 (-3.71%)
(Updated: September 7, 2024 at 6:57 AM ET)

SpringWorks Therapeutics Key Stats

Sell
22
SpringWorks Therapeutics (SWTX) is a Sell
Day range:
$38.46 - $40.54
52-week range:
$18.00 - $53.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.16%
Volume:
320.5K
Avg. volume:
890.9K
1-year change:
39.51%
Market cap:
$2.9B
Revenue:
$5.4M
EPS:
$-4.44

How Much Does SpringWorks Therapeutics Make?

Data Unavailable

Is SpringWorks Therapeutics Growing As A Company?

Data Unavailable

SpringWorks Therapeutics Stock Price Performance

What Is SpringWorks Therapeutics 52-Week High & Low?

SpringWorks Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SpringWorks Therapeutics?

Is SpringWorks Therapeutics Cash Flow Positive?

  • What Is SWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$233.9M
  • What Is SpringWorks Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $301.6M
  • What Is SpringWorks Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$102.9M

SpringWorks Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SWTX return on invested capital is -57.97%
  • What Is SpringWorks Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -50.43%
  • What Is SWTX Return On Equity?
    ROE is a measure of profitability and is -57.97%

SpringWorks Therapeutics Earnings Date & Stock Price

SpringWorks Therapeutics Competitors

SpringWorks Therapeutics Dividend Yield

SpringWorks Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 49.3%
Revenue: 0% 72.74%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 68.13
Upside from Last Price: 76.03%

Major Shareholders

  • How many SWTX shares are owned by institutional investors?
    124.6M SWTX shares are owned by institutional investors
  • How many SWTX shares are owned by insiders?
    2.9M SWTX shares are owned by insiders